HL7 progressing on next generation standards

Health Level Seven International's (HL7) next generation standards framework is progressing and will be balloted as a Draft Standard for Trial Use.

Fast Health Interoperable Resources (FHIR) combines features of HL7’s current Version 2, Version 3 and CDA integration product lines, while using new web standards and having an enhanced focus on ease of implementation, according to the organization's webpage on the topic. “FHIR solutions are built from a set of modular components called ‘Resources.’ These resources can easily be assembled into working systems that solve real-world clinical and administrative problems at a fraction of the price of existing alternatives.” FHIR combines the best features of HL7’s Version 2, Version 3 and CDA product lines while leveraging the latest web standards and applying a tight focus on implementability. FHIR is suitable for use in a wide variety of contexts, including social media on mobile phones, cloud communications, EHR-based data sharing and server communication in large institutional healthcare providers.

If sufficient HL7 members approve the ballot, it will be available for testing in real-world applications to gather information on necessary enhancements. FHIR is currently being tested within HL7 and will be available as a draft standard later this year, with development likely done by the end of 2015. More information is available here.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.